🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The present study is a phase I, single-centre, double-blind, randomized, cr...
Status
Completed
Location
Diabeteszentrum Bad Lauterberg
Start Date
2011-11
Trial ID
NCT02749032
Treatments Being Tested
Insulin is normally not bioavailable when taken through the oral route, as ...
Status
Suspended
Location
Karolinska Trial Alliance, Phase I Unit
Start Date
2009-09
Trial ID
NCT00990444
Treatments Being Tested
Primary Objective: To demonstrate the superiority of sotagliflozin 400 mil...
Status
Completed
Location
Investigational Site Number 8406028
Start Date
2017-09-15
Trial ID
NCT03285594
Treatments Being Tested
Effect of Dapagliflozin on 24-hour Blood Glucose in Type 2 Diabetes Patient...
Status
Completed
Location
Research Site
Start Date
2015-05
Trial ID
NCT02429258
Primary Objective: To evaluate the ability of lixisenatide to modulate pos...
Status
Terminated
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02274740
Treatments Being Tested
The purpose of the study is to assess the effect of the addition of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-20
Trial ID
NCT02532855
The study was designed to investigate the optimal management of hyperglycem...
Status
Completed
Location
Diabetes and Endocrine Associates La Mesa Location
Start Date
2014-05-23
Trial ID
NCT02060383
Treatments Being Tested
The purpose of this study is to compare the safety and efficacy of the stud...
Status
Completed
Location
Valley Endocrine, Fresno
Start Date
2019-08-30
Trial ID
NCT04039503
Treatments Being Tested
Primary Objective: To demonstrate the superiority of the insulin glargine/...
Status
Completed
Location
Investigational Site Number 8400064
Start Date
2016-07-06
Trial ID
NCT02787551
Primary Objective: To assess the mean change in HbA1c (glycated haemoglobi...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-30
Trial ID
NCT02954692